Incidence, mitigation, and management of neurologic adverse events in patients with multiple myeloma (MM) treated with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-2 Meeting Abstract
| Authors: | Einsele, H.; Parekh, S. S.; Madduri, D.; Santomasso, B.; De Larraya, J. G. P.; van de Donk, N. W. C. J.; Arnulf, B.; Mateos, M. V.; De Braganca, K. C.; Varsos, H.; Carrasco-Alfonso, M.; Akram, M.; Lendvai, N.; Jackson, C. C.; Olyslager, Y.; Zudaire, E.; Li, C.; Geng, D.; Jakubowiak, A. J.; Cohen, A. D. |
| Abstract Title: | Incidence, mitigation, and management of neurologic adverse events in patients with multiple myeloma (MM) treated with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-2 |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120604191 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.8028 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8028 -- Source: Wos |
